全关节置换术的头孢唑林预防:肥胖患者常剂量不足且假体周围感染风险增加
该回顾性研究纳入2005至2017年17,393例接受头孢唑林围手术期预防的初次全关节置换术,按体重和抗生素剂量分为剂量不足组与剂量充足组。体重超过120 kg者95.9%(944/984)剂量不足,剂量不足组1年假体周围感染率高于剂量充足组(1.51% vs 0.86%,P = .002),体重超过120 kg者1年感染率高于体重不足120 kg者(3.25% vs 0.83%,P < .001)。作者认为骨科医生应关注围手术期基于体重的抗生素给药。
要点
- 体重超过120 kg的患者中95.9%(944/984)头孢唑林剂量不足。
- 剂量不足组1年假体周围感染率高于剂量充足组(1.51% vs 0.86%,P = .002)。
- 体重超过120 kg者1年感染率高于体重不足120 kg者(3.25% vs 0.83%,P < .001)。
核心结论
- 头孢唑林剂量不足常见,尤其是体重超过120 kg的患者。
- 本研究报告剂量不足患者更可能发生假体周围感染。
- 作者认为骨科医生应关注围手术期基于体重的抗生素给药以避免增加假体周围感染风险。
研究设计与样本
- 回顾性研究纳入2005至2017年17,393例接受头孢唑林围手术期预防的初次全关节置换术。
- 按患者体重和抗生素剂量分为剂量不足组与剂量充足组。
- 识别指数手术后1年内发生假体周围感染的患者。
- 采用双变量和多因素logistic回归分析控制潜在混杂因素并识别假体周围感染危险因素。
主要发现
- 体重超过120 kg的患者中95.9%(944/984)剂量不足。
- 剂量不足组1年假体周围感染率高于剂量充足组(1.51% vs 0.86%,P = .002)。
- 体重超过120 kg者1年假体周围感染率高于体重不足120 kg者(3.25% vs 0.83%,P < .001)。
- 剂量不足(比值比1.665;P = .006)且合并症更多(比值比1.259;P < .001)的患者1年内更可能发生假体周围感染。
关键数值与推荐
- 剂量不足组1年假体周围感染率为1.51%,剂量充足组为0.86%(P = .002)。
- 体重超过120 kg者1年假体周围感染率为3.25%,体重不足120 kg者为0.83%(P < .001)。
- 体重超过120 kg者中剂量不足比例为95.9%(944/984)。
- 剂量不足的比值比为1.665(P = .006),合并症更多的比值比为1.259(P < .001)。
临床怎么用
- 作者认为骨科医生应关注围手术期基于体重的抗生素给药以避免增加假体周围感染风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: One of the most effective prophylactic strategies against periprosthetic joint infection (PJI) is administration of perioperative antibiotics. Many orthopedic surgeons are unaware of the weight-based dosing protocol for cefazolin. This study aimed at elucidating what proportion of patients receiving cefazolin prophylaxis are underdosed and whether this increases the risk of PJI. METHODS: A retrospective study of 17,393 primary total joint arthroplasties receiving cefazolin as perioperative prophylaxis from 2005 to 2017 was performed. Patients were stratified into 2 groups (underdosed and adequately dosed) based on patient weight and antibiotic dosage. Patients who developed PJI within 1 year following index procedure were identified. A bivariate and multiple logistic regression analyses were performed to control for potential confounders and identify risk factors for PJI. RESULTS: The majority of patients weighing greater than 120 kg (95.9%, 944/984) were underdosed. Underdosed patients had a higher rate of PJI at 1 year compared with adequately dosed patients (1.51% vs 0.86%, P = .002). Patients weighing greater than 120 kg had higher 1-year PJI rate than patients weighing less than 120 kg (3.25% vs 0.83%, P < .001). Patients who were underdosed (odds ratio, 1.665; P = .006) with greater comorbidities (odds ratio, 1.259; P < .001) were more likely to develop PJI at 1 year. CONCLUSION: Cefazolin underdosing is common, especially for patients weighing more than 120 kg. Our study reports that underdosed patients were more likely to develop PJI. Orthopedic surgeons should pay attention to the weight-based dosing of antibiotics in the perioperative period to avoid increasing risk of PJI.
引用
- Rondon AJ, Kheir MM, Tan TL, et al. Cefazolin Prophylaxis for Total Joint Arthroplasty: Obese Patients Are Frequently Underdosed and at Increased Risk of Periprosthetic Joint Infection. J Arthroplasty. 2018. PMID: 30093266. doi:10.1016/j.arth.2018.06.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。